A large number of chemicals induce or exacerbate autoimmune-like diseases in man. Because of the complexity of processes involved, these adverse effects are often if not always missed in standard toxicity testing. To date no validated and generally applicable predictive animal model exists and only a few chemicals have actually been shown to induce adverse autoimmune effects in certain animals. The popliteal lymph node assay (PLNA) is a very promising animal test to (pre)screen for systemic immunosensitizing, including autoimmunogenic potential. This review describes the essentials of the various PLNAs against the background of current understanding of chemically induced systemic immunostimulation. The most simple primary PLNA measures enlargement of the popliteal lymph node 6-8 days after subcutaneous injection of a chemical into the footpad. The primary PLNA can distinguish between immunostimulating (both sensitizers and irritants) and innocent chemicals but does not assess the involvement of T cells or immunosensitization. For this, but also for elucidation of relevant mechanisms, detection of anamnestic responses in secondary PLNAs or responses to reporter antigens in the modified PLNA are suitable. To date over 100 compounds (drugs and environmental pollutants) have been tested, and results show a good correlation with reported immunostimulating (both autoimmunogenic and allergic) potential. Importantly, no false-negative chemicals were detected if metabolism was considered. The various types of the PLNA, but in particular the secondary and modified PLNAs, await extensive validation before they can be recommended as a standard test for autoimmunogenic potential. Key words: autoimmunity, chemicals, popliteal lymph node assay, reporter antigens. -Environ Health Perspect 1 07(suppl 5): 673-677 (1999). http.//ehpnet1.niehs.nih.gov/docs/1999/suppl-5/673-677pieters/abstract html
Various drugs and environmental chemicals or metabolites thereof collectively referred to as low molecular weight compounds [LMWCs] generally less then 1,000 Da can provoke the onset of autoimmune diseases (AID) (1) (2) (3) (4) . The pathogenesis of AID is a multifactorial and complex process, involving a large number of predisposing factors (major histocompatabiity complex [MHC] haplotype, gender, metabolism, concurrent infections). Not surprisingly, it has proven very difficult to develop animal models that mimic certain AID, let alone LMWC-induced AID. Consequently, no generally applicable predictive animal models exist using symptomatic AID as an end point and a chemical's capacity to induce or exacerbate AID in man is hardly if ever recognized in standard toxicity testing (1) . Reasonably, predictive test models for autoimmunogenic potential of xenobiotics should rely on detection of initiating immune responses rather than on symptomatic AID. The presently available popliteal lymph node assays (PLNAs) are very promising test systems that focus largely on initiating immunostimulatory effects ofchemicals.
Autoimmune diseases are the ultimate clinical consequence of destructive immune responses triggered by unregulated adaptive responses to autoantigens (1, 2, 5) . These unregulated adaptive immune responses are the consequence of breakthrough of immunologic tolerance and subsequent activation of autoreactive lymphocytes. According to current understanding in immunology, lymphocytes require two signals to become activated. Signal 1 is provided by receptors upon recognition of a specific antigen and signal 2 is antigen-nonspecific and provided by costimulatory molecules and cytokines. Peripheral and probably also central tolerance is accomplished by recognition of an adequate antigen or reception of signal 1 in the absence of a nonspecific costimulatory or "helping" signal 2 (5,6 ). Consistently, induction of self-tolerance involves specific recognition of autoantigen leading to selective inactivation or destruction of autoreactive lymphocytes, and tolerance only exists for dominant autoantigens/epitopes. Signal 2 alone does not elicit an immune reaction (7) .
To fully understand the strengths but also the limitations of the PLNA, we need to consider how the generation of signal 1 The adoptive transfer PLNA has been used extensively by Gleichmann and colleagues, and in addition to proving the involvement of T cells for some chemicals they were also able to eliminate a number of false-negative autoimmunogenic chemicals (procainamide, propylthiouracil [PTU], and Au+) by detecting memory T-cell responses to their metabolites (n-hydroxyl-amino-procainamide), PTU-SO3-, Au3+) (13) (14) (15) .
These false-negative LMWC appeared to require bioactivation, which apparently is not sufficiently available in the uninflamed paw. Bioactivation, however, can be easily introduced into the PLNA by coinjection of an S9 mix or activated phagocytes.
Results obtained with the adoptive PLNA have also shown that mice immunized with the untreated non-self-model antigen bovine RNase in adjuvant respond exclusively to dominant epitopes, whereas injection of RNase preincubated with Au(III) elicits additional T-cell responses to cryptic epitopes (16) . Using the adoptive transfer PLNA, it was also demonstrated that T cells, isolated shortly after initiating an autoimmune response with HgC12, responded exclusively to unidentified mercury-modified selfproteins; later in the response, T cells responding to unmodified self-proteins were detectable as well (17) . The The Modified PLNA In the recently introduced modified PLNA, the local 2,4,6-trinitrophenyl (TNP)-specific antibody response to well-defined antigens TNP-ovalbumin (TNP-OVA) or TNP-Ficoll is analyzed after coinjection with a given LMWC (18) . These antigens are chosen because they need different and (in relation to LMWC-induced autoimmune responses) relevant conditions to elicit a TNP-specific antibody response. A TNP-specific IgG response to the T-cell-independent antigen TNP-Ficoll can only occur in the presence of T-cell help, which is noncognate. Hence, in case of co-injection with an LMWC, a TNP-specific IgG reponse to TNP-Ficoll indicates soluble help from hapten of neoantigen-specific T cells (Figure 2) (26) .
The T-cell-dependent antigen TNP-OVA, which requires cognate T-B cell interaction, is used in such a low dose (10 The IgG response to these two reporter antigens may be used to discriminate between compounds that create neoantigens and thereby activate T cells (positive IgG response to both TNP-Ficoll and TNP-OVA, e.g., HgC12 [ Figure 3] ) and compounds that only cause an inflammatory response and do not sensitize neoantigen-specific T cells [positive response to TNP-OVA but not to TNPFicoll, e.g., the irritant glutaric anhydride or the macrophage stimulator silica (Figure 3) ] (18) . Surprisingly, the classic irritant sodium dodecyl sulfate induced a IgG1 response to TNP-Ficoll, suggesting that this compound induces formation of neoantigens upon subcutaneous exposure (Figure 3 (30) , and silica (31) . Allergenic compounds (e.g., dinitrochlorobenzene) (23) also induce a positive PLN index; the response in the PLNA appears to be dose dependent (23) and to vary with genetic background (both MHC and non-MHC genes) of the animals (31) (32) (33) (34) . PLN Figure 3) unpublished observations] as well as a few drugs such as quinacrine and niridazol (23) .
Concluding Remarks
To date, no generally applicable predictive animal models for autoimmunogenic potential of LMWC exist or are expected in the near future. However, the immunostimulating potential of LMWC can be screened in the primary PLNA, a simple, rapid, and objective assay to test an array of xenobiotics such as newly synthesized and structurally homologous drugs. Distinction of the involvement of T cells and discrimination between sensitizing and irritant LMWC can be accomplished in one of the two secondary PLNAs; however, the adoptive transfer PLNA cannot be regarded as an early screening assay. The modified PLNA appears to be a very promising extension of the primary PLNA and a simple and fast assay to indicate the involvement of T cells. A possible strategic flow scheme that may help to decide which PLNA is most useful in a certain occasion is depicted in Figure 4 .
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